A CTC Count finds existing escapee CTCs in a blood sample and counts them. A CTC count every 3-6 months can be used to monitor the effectiveness of cancer treatment and assess changes in aggressiveness. This test is the best way of closely monitoring the status of a person's cancer.

Customised Chemosensitivity exposes a person's CTCs to recommended chemotherapy or other cancer killing agents, as selected by healthcare practitioners. This test is to see which therapy or therapy combination is most effective at killing a person's CTCs. CTCs that survive exposure are said to be resistant while CTCs that are killed by exposure are said to be sensitive.

Companion Diagnostics identifies the presence of receptors on a person's CTCs that may be specifically targeted by certain cancer treatments. Practitioners can also choose to test for other 'biomarkers' that indicate important factors, such as aggression and activity. This test helps practitioners select treatments to target the unique nature of each person's cancer

Tumour Sphere Units tests to see if a person's CTCs can multiply to form microscopic clusters, called Tumour Sphere Units, in the laboratory. CTCs that can form clusters have stem-cell qualities, rendering them more resistant to treatment and capable of forming a second tumour, called a metastasis

Escapee cancer cells in the blood can be found by a simple blood test

Escapee cancer cells in the blood, or 'CTCs' as they are known, can be found by a simple blood test. A CTC Count test finds existing escapee cancer cells (CTCs) in a blood sample and counts them. Monitoring changes in cancer activity over time is made easy with this test... To learn more, please visit our patient or practitioner information page.

Some CTCs can hide in the blood stream for months or years before activating and forming a second tumour. Some CTCs may even resist treatment. This test analyses how a person's CTCs respond when exposed to a recommended chemotherapy regimen or botanical treatment. To learn more, please visit our patient or practitioner information page.

Biomarker analysis can be used to identify receptors that are targets for treatment, to assess the potential for cancer spread or to assist in diagnosis. The identification of certain receptors on a person's CTCs may help practitioners design personalised treatment strategies. To learn more, please visit our patient or practitioner information page.

Tumour Sphere Units tests to see if a person’s CTCs can multiply to form microscopic clusters, called Tumour Sphere Units in the laboratory. CTCs that can form clusters have stem-cell qualities, rendering them more resistant to treatment and capable of forming a second tumour, called a metastasis...more info

To order a test, download the request form and take it with youto the next appointment with your treating healthcare practitioner.

MEDICAL ADVICE DISCLAIMER: By visiting the Genostics website, you have agreed that you accept the Medical Advice Disclaimer here stated and are willing to visit the Genostics website. The information on any page in the Genostics website, together with all information within any written, audio, downloadable material and other media, as well as information on external links provided on the Genostics website, as well as information on any printed or digital material distributed by Genostics is for education purposes only. It is not intended nor implied to be a substitute for professional medical advice. The reader should always consult his or her Health Practitioner to determine the appropriateness of the information for their own situation or if they have any questions regarding a medical condition or treatment plan. Reading the information within this webpage does not create a Health Practitioner - Patient relationship. Genostics does not offer any medical advice. Genostics does not engage in medical practice. Do not use this information to disregard any medical advice, nor to delay seeking medical advice because of something you have read or seen within this website. No warranty is given as to the accuracy of information contained or connected to this website, and persons who rely on it do so at their own risk.

IMAGES, LINKS & COPYRIGHT: Some images on the Genostics website and printed material are public domain. For these images, the source has been credited as a watermark on the bottom left hand corner of the image. All other images including logos are copyright Genostics and are not available for reuse. All text on the Genostics website, digitial and printed material is copyright Genostics and not available for reuse. Use of images on the Genostics website and printed material does not imply any relationship between Genostics and the image source, nor does it imply any endorsement of Genostics by the image source and vice versa. The presence of external links provided on the Genostics website, digital and printed media does not imply any relationship between Genostics and the company owning the domain that has been linked, nor does it imply any endorsement of Genostics by the company owning the linked domain and vice versa.